Regulatory CD41 T cells are important for the homeostasis of the immune system and their absence correlates with autoimmune disorders. Here, we investigate the capacity of IL-27, a cytokine with proand anti-inflammatory properties, to regulate the generation of transforming growth factor b (TGFb)-inducible forkhead box P3 (Foxp3)-positive regulatory T (Treg) cells. Our results demonstrate that IL-27 inhibits the acquisition of the Treg phenotype at the level of Foxp3, CD25 and CTLA-4 (CD152) expression as well as the suppressive function. In contrast to TGFb-induced Treg cells, the cells generated after differentiation in the presence of TGFb and IL-27 maintained the ability for IL-2 and tumour necrosis factor a (TNFa) production. The inhibitory effect of IL-27 on Treg generation was at least partially signal transducer and activator of transcription 3 (STAT3) dependent as examined by targeted STAT3 protein inhibition using small interfering RNA (siRNA), while STAT1-dependent signals seemed to oppose the STAT3 signals. In turn, TGFb blocked IL-27-induced T h 1 differentiation. Thus, IL-27 and TGFb mutually control their effects on CD41 T-cell differentiation, whereby IL-27 favours inflammatory conditions through a STAT3-dependent inhibition of Treg generation.
IL-27 inhibits the development of regulatory T cells via STAT3
IL-27 is a heterodimeric cytokine which consists of p28 and Epstein-Barr-induced gene 3 (Ebi3) subunits. The p28 chain is related to IL-12p35 and has a classical cytokine structure, whereas the Ebi3 is related to IL12p40 and structurally resembles the soluble IL-6Ra chain (1) . IL-27 is expressed predominantly by antigen-presenting cells (APCs) and the production of both subunits can be induced by Toll-like receptor ligands such as LPS, Poly I:C and by intact Escherichia coli (1) (2) (3) . Additionally, signalling via CD40L and IL-1b can up-regulate the Ebi3 subunit, whereas p28 has been shown to be up-regulated by IFNc (3, 4) .
The IL-27 receptor is composed of the ligand-specific IL-27Ra chain (WSX-1, T-cell cytokine receptor) and of gp130, a signal-transducing molecule shared with other cytokines such as IL-6 and IL-11. IL-27 is capable of binding to IL-27Ra in the absence of gp130. However, the co-expression of both receptor subunits is required for signal transduction (5) . IL-27Ra expression is restricted to immune cells, such as T cells, NK cells, mast cells, monocytes, neutrophils and B cells (5, 6) . Among different T-cell populations, IL-27Ra is expressed at the highest level on effector, regulatory and memory cells (7) . Upon ligand binding the phosphorylation of STAT1 and STAT3 in T h cells occurs (8) (9) (10) .
Stimulation of T h in the presence of IL-27 induces the expression of the signature T h 1 cytokine IFNc via up-regulation of the transcription factor T-bet and consequently of the IL-12Rb2 chain. This effect of IL-27 depends on multiple signalling pathways such as STAT1 and p38 mitogen-activated protein kinase (8) (9) (10) (11) (12) . Consistent with its activity as a T h 1 permissive factor, IL-27 suppresses the differentiation of T h 2 by blocking the expression of GATA3 (9, 13) . Additionally, IL-27 inhibits the differentiation of T h 17 (14, 15) . Both suppressive effects of IL-27 are dependent on the STAT1 signalling pathway. Another inhibitory effect of IL-27 on T h function, which is mediated via STAT1, is the inhibition of IL-2 production and IL-2-dependent proliferation (16, 17) . Thus, in T h , IL-27 uses STAT1 signalling for different effects: first, for promotion of T h 1 differentiation; second, for the suppression of IL-2 production and proliferation and finally, for the inhibition of T h 2 and T h 17 differentiation. Although IL-27 induces strong phosphorylation of STAT3 as well, little is known about the role of that molecule for the IL-27-mediated effects on T h function. So far, STAT3 activation has been shown to be partially involved in IL-27-mediated suppressive effects on IL-2, IL-4 and IL-17 production in fully activated T h (18) .
Treg cells comprise a population of CD4+CD25+ cells, which exert inhibitory effects on the function of other T cells, and attenuates immune responses against self-or nonself-antigens (19, 20) . Naturally occurring Treg cells are generated in the thymus as a functionally distinct T-cell subpopulation (20) , whereas adaptive Treg cells are induced from naive T cells in the periphery and transforming growth factor b (TGFb) is critical for the maintenance of these cells (21, 22) . Most Treg cells express the transcription factor Foxp3 which is necessary and sufficient for their development and function (23, 24) . Mutation of Foxp3 in mice results in early autoimmune disease (25) , whereas mutations of human Foxp3 are associated with a disorder termed immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (26, 27) .
The generation of Treg cells by TGFb can be inhibited by IL-6 which concomitantly promotes the development of T h 17 (28, 29) . Thus, the differentiation of Treg cells and T h 17 by TGFb appears to be reciprocally related, through the action of IL-6. This IL-6-dependent negative effect on the generation of Treg cells has been shown to be mediated by the transcription factor STAT3 (30) (31) (32) . While our manuscript was prepared, publications appeared showing that the in vitro generation of Treg cells can also be repressed by IL-27, although the mechanism of this inhibition remained unexplored (33, 34) . As the common feature of IL-27 and IL-6 signalling is the activation of STAT3 (35), we hypothesized that IL-27-like IL-6 could exert its inhibitory effect on TGFb-mediated Treg cell development via STAT3. Here, we use STAT1-deficient (STAT1À/À) mice and siRNA-mediated transient down-regulation of STAT3 protein expression to demonstrate that the suppressive effect of IL-27 on TGFb-induced Treg generation is at least partially mediated via STAT3, but not via STAT1.
Methods

CD4+ cell purification and in vitro stimulation
Wild-type (WT) C57BL/6 mice were purchased from the Jackson Laboratory. STAT1À/À mice were provided by T. Decker (University of Vienna). Naive CD4+CD62L+ T cells were prepared by magnetic cell sorting (MACS, Miltenyi, Bergisch Gladbach, Germany) from spleens and lymph nodes of 6-to 8-week old WT or STAT1À/À mice. The sorted cells (>97% purity) were primed with immobilized anti-CD3 (5 lg ml À1 ; clone 145-2C11) and soluble anti-CD28 antibodies (2.5 lg ml À1 ; clone 37.51) for 72 h in the presence of recombinant human (rh) IL-2 (50 U ml À1 ) and neutralizing anti-IL-4 (10% culture supernatant of clone 11B11) plus antiIFNc (8 lg ml À1 ; clone XMG1.2). Then, the cells were rested for 48 h in the presence of rhIL-2 (50 U ml À1 ) and finally restimulated for 5 h (for intracellular staining) or for 6 h (for measurement of cytokines in culture supernatants) with immobilized 5 lg ml À1 anti-CD3 as previously described (36) . Cells stimulated under neutral conditions (anti-IL-4 plus anti-IFNc and rhIL-2) were considered as T h 0. For Treg differentiation, cultures also received 2 ng ml À1 rhTGFb1 (Biosource). Where indicated, cells received 20 ng ml À1 of recombinant murine (rm) IL-27 (R&D Systems). Some cultures were induced to differentiate into T h 17 by addition of anti-IL-4, anti-IFNc, rhIL-2 and a mixture of 2 ng ml À1 rhTGFb1 plus 50 ng ml À1 rmIL-6 (PeproTech). In some experiments, the amounts of IL-2, tumour necrosis factor a (TNFa) and IFNc secreted by activated cells were measured by ELISA (BD).
Proliferation assays
CD4+CD25+ cells were prepared by MACS depletion of CD8+, B220+ and CD11c+ cells from splenic and lymph node cells followed by positive selection of CD25+ cells using anti-CD25-PE plus anti-PE beads. The purity of the resulting CD4+CD25+ T cells ranged from 95 to 98%. The CD4+CD25À T-cell fraction was used as responder cells (95% purity). T-depleted spleen cells were irradiated with 25 Gy and used as APCs. WT C57BL/6 CD4+CD25À (5 3 10 
Surface and intracellular staining
Intracellular levels of Foxp3, IL-2, IL-4, IFNc and IL-17 were measured during differentiation of cells after the indicated time points or 5 h after re-stimulation. Brefeldin A (10 lg ml À1 ) was added for the final 4 h of the respective cell culture. The cells were harvested, fixed, permeabilized and stained as described previously (36) using the following mAbs: anti-Foxp3-PE, anti-IL-17-PE (eBioscience), anti-IL-2-FITC, anti-IL-4-FITC, anti-IFNc-PE and anti-CTLA-4-PE (all from BD). Anti-CD25-CY mAb (BD) was used to detect surface CD25.
Quantitative real-time PCR
Total RNA was isolated from cell pellets using the High Pure RNA Isolation Kit (Roche). cDNA synthesis was performed using the RevertAid TM First Strand cDNA Synthesis Kit (MBI Fermentas) according to the manufacturer's instructions. Quantitative real-time TaqMan PCR to determine mRNA expression of T-bet, IFNc and hypoxanthine-guanine phosphoribosyl transferase (HPRT) was performed on an ABI Prism 7700 Sequence Detection System (Applied Biosystems) using the qPCR TM Core Kit (Eurogentec). Sequencespecific amplification was detected with an increased fluorescent signal of the reporter dye FAM during the amplification cycles. Thermocycler conditions consisted of an initial step at 95°C for 10 min, followed by 40 cycles of a two-step PCR programme consisting of 95°C for 15 s and 60°C for 60 s. Standard curves were set up for IFNc, T-bet and HPRT, and the mRNA expression of IFNc or T-bet was normalized to the expression of HPRT using the standard curve method. Thereafter, normalized mRNA expression levels of IFNc or T-bet in T h 0 were given as an arbitrary value of 1.0 and the remaining samples were plotted relative to that value. Immunoblotting CD4+ T cells isolated from WT mice were primed under T h 0 conditions or in the presence of rhTGFb1 as described above. For the STAT1 and STAT3 immunoblots, cells were primed for 24 h, harvested, washed, rested at 37°C for 2 h and left untreated or treated with 20 ng ml À1 rmIL-27 for 20, 60 or 120 min. For the siRNA experiments, cells were nucleofected as described below and subsequently primed as described above in the presence of 20 ng ml À1 rmIL-27 and 2 ng ml À1 rhTGFb1. After 48 h of culture, the cells were harvested. In all cases, cell stimulation was terminated by washing the cells in ice-cold PBS, and then the cells were lysed by sonification in a 40-mM Tris buffer (pH 8.0) containing a protease inhibitor mixture composed of 100 lM phenylmethylsulphonylfluoride (Sigma), 1 lg ml À1 chymostatin, 5 lg ml À1 pepstatin A, 5 lg ml À1 aprotinin and 5 lg ml À1 leupeptin (all from Biomol). Cell lysates were fractionated by SDS-PAGE, transferred to nitrocellulose membranes and immunoblotted using antibodies recognizing phospho-STAT1 (Tyr701) and phospho-STAT3 (Tyr705; both from Cell Signaling Technology). Total STAT1 and STAT3 levels were assessed using anti-STAT1 (#9171) or STAT3 (124H6) antibodies (both from Cell Signaling Technology). Protein loading was evaluated by blotting with anti-b-actin antibodies (Sigma-Aldrich).
Nucleofection
WT CD4+ cells purified as described above were immediately nucleofected with STAT3 siRNA-1 and -2 or with scrambled control siRNA (IBA, Gö tingen, Germany). The siRNA-1 and -2 were designed on the basis of the published sequences (37, 38) , respectively, kindly provided by A. Scheffold (Deutsches Rheume-Forschungszentrum, Berlin, Germany) and prepared by IBA. Nucleofection of 5 3 10 6 cells in 100 ll of mouse T-cell Nucleofectorâ solution (Amaxa, Kö ln, Germany) was performed using 500 pmol total of siRNAs and the W001 program of the Nucleofector TM II machine (Amaxa). The nucleofected cells were primed in the presence of 2 ng ml À1 rhTGFb1, as described above. Where indicated, the cells received 20 ng ml À1 rmIL-27 or 50 ng ml À1 rmIL-6. After 72 h of differentiation, the cells were harvested, fixed, permeablized, stained with Foxp3-PE or IFNc-PE mAb and finally analysed by flow cytometry. Brefeldin A was added to the cultures 4 h before analysis. The sequences of the siRNAs were as follows: STAT3 siRNA-1, 5#-CCAACAUCUGCCUGGACCGTCTGTT-3#; STAT3 siRNA-2, 5#-UCAACUUCAGACCCGUCAACAAATT-3# and scrambled siRNA, 5#-CUGAGAGUAUUUCGAGACGAAAA-3#.
Statistical analysis
The two-tailed Student's t-test was used for statistical analysis. P values of <0.05 were considered as significant.
Results
IL-27 inhibits Treg cell generation and simultaneously maintains IL-2 production by TGFb-treated CD4+ T cells
We examined the potential role of IL-27 in Treg cell generation by using several approaches. As Foxp3 expression in the mouse appears to be highly restricted to Treg cells and therefore is a very useful marker for the specific detection of these cells (23, 24) , we first assessed the expression of Foxp3 in T h during differentiation and after re-stimulation, by intracellular staining. Therefore, we stimulated naive T h via TCR/CD28 without additional cytokines (T h 0 conditions) or in the presence or absence of IL-27 and TGFb alone or in combination. After 24, 48 and 72 h of differentiation and after re-stimulation, we stained Foxp3 intracellularly (Fig. 1A) . Culture of the CD4+ T cells with TGFb promoted the generation of Treg cells through induction of Foxp3 expression, as expected, and this effect was detectable already after 48 h of cell differentiation. At the same time point, IL-27 effectively blocked the TGFb-induced Foxp3 expression (Fig.  1A) . The IL-27-mediated suppression of Foxp3 expression was maintained after 72 h of cell differentiation and after restimulation (Fig. 1A) . These results confirm recently published data showing an inhibitory effect of IL-27 on Treg cell generation (33, 34) .
Since TGFb promotes the development of Treg cells through Foxp3 induction and concomitantly Foxp3 downregulates IL-2 gene transcription, differentiated Foxp3+ Treg cells do not produce this cytokine (23, 24, 39) . Consequently, Foxp3 expression and IL-2 production are reciprocally related. Because IL-27 inhibits Foxp3 expression, we hypothesized that IL-27 may also influence IL-2 production by TGFb-treated CD4+ T cells. Therefore, we tested culture supernatants from the CD4+ T cells described in Fig. 1(A) for the presence of IL-2 by ELISA (Fig. 1B and C) . As expected, TGFb inhibited IL-2 production by differentiating cells, whereas addition of IL-27 to these cell cultures blocked the suppressive effect of TGFb, again already after 48 h of differentiation, leading to maintenance of IL-2 production (Fig. 1B) . This effect of IL-27 became much more pronounced at 72 h after the onset of cell cultures. However, the amounts of IL-2 in IL-27-treated cultures were still significantly lower than in T h 0 cultures tested at the same time point (compare Fig. 1B and C) . In contrast, after re-stimulation, the IL-2 amounts produced by cells after incubation in the presence of TGFb and IL-27 achieved the T h 0 level (compare Fig. 1B and C) . Thus, IL-27-mediated down-regulation of Foxp3 expression is accompanied by increased IL-2 production by arising T h . On the other hand, as shown in Fig.  1(C) , we confirm previous results describing an IL-27-mediated inhibitory effect on IL-2 production for CD4+ T cells cultured under T h 0 conditions, i.e. in the absence of TGFb (16) (17) (18) . To sum up, these data suggest a previously not appreciated double-sided role of IL-27 for IL-2 production: one as inducer in the presence of TGFb and the other as an attenuator under T h 0 conditions. In order to study more closely the reciprocal effects of IL-27, IL-2 production and Foxp3 expression were analysed in CD4+ T cell differentiated for 72 h in the presence of TGFb and titrated amounts of IL-27. As shown in Fig. 2(A) , IL-27 dose dependently inhibited TGFb-mediated Foxp3 expression and, conversely, dose dependently up-regulated IL-2 production in the presence of TGFb (Fig. 2B) . The strongest inhibitory effect of IL-27 on Foxp3 expression and concomitantly the highest amounts of IL-2 were detectable at a concentration of 100 ng ml À1 ( Fig. 2A and B) . At the same time, under T h 0 conditions, IL-27 dose dependently inhibited the IL-2 production; however, here a plateau was already reached at a concentration of 5 ng ml À1 (Fig. 2C ). This observation suggests different mechanisms operating during IL-27-mediated suppression and induction of IL-2 production. The inhibition of IL-2 expression by IL-27 was previously described to be mediated via STAT1 (17) , whereas the maintenance of IL-2 production is possibly favoured by down-regulation of Foxp3.
As IL-27 has also been shown to inhibit the IL-2-dependent proliferation of differentiating T h (17), we examined whether IL-27 negatively regulates Treg cell differentiation via suppression of their growth. However, no differences were detectible between cells cultured in the presence of TGFb alone or in combination with IL-27 as assessed by a [ 3 H] thymidine assay 72 h after start of cell differentiation (data not shown). In summary, these data illustrate a specific negative effect of IL-27 on the differentiation of Treg cells by inhibition of Foxp3 expression and concomitant reciprocal up-regulation of IL-2.
IL-27 inhibits the expression of Treg-related makers and Treg function
Treg cells are phenotypically characterized by high-level expression of CD25 on their surface and by increased expression of CTLA-4 (23, 24, 39) . Therefore, we examined the expression of these Treg-associated molecules after differentiation of naive T h in the presence of TGFb and IL-27 alone or in combination. As expected, stimulation via TCR/ CD28 in the presence of TGFb led to strong up-regulation of CD25 and CTLA-4 ( Fig. 3A and B) . The addition of IL-27 to TGFb cell cultures suppressed the expression of both Treg markers (Fig. 3A and B) . Thus, IL-27 inhibits not only the expression of Foxp3 but also the acquirement of the Treg-associated molecules CD25 and CTLA-4 by differentiating T h .
Functionally, Treg cells are able to suppress the proliferation of other T cells in vitro by inhibiting the capacity of the responder cells to produce IL-2 and to proliferate. This suppression requires stimulation of Treg cells via their TCR and is usually mediated by a cell-contact-dependent mechanism (23, 39) . To examine, whether IL-27 influences the suppressive function of Treg cells, we performed proliferation assays (Fig. 3C) . We isolated conventional CD4+CD25À responder T cells, stimulated them with soluble anti-CD3 antibodies in the presence of APC and mixed them at the indicated ratios with two different types of suppressor cells. The suppressor cells were obtained from naive CD4+ T cells after 72 h in vitro differentiation with either TGFb alone or in combination with IL-27. At the onset of the mixed culture, 63.8% of TGFb, but only 14.2% of TGFb plus IL-27-treated cells were Foxp3 positive (Fig. 1A) . After 72 h of co-culture, we measured cell proliferation by [ 3 H] thymidine incorporation. While CD4+CD25À cells alone proliferated well, their proliferation was efficiently inhibited by suppressor cells which had been induced with TGFb alone, demonstrating that TGFb does induce bona fide Treg cells. These in vitro induced Treg cells inhibited the proliferation of responder cells at the same level as ex vivo isolated natural CD4+ CD25+ Treg cells (data not shown). In contrast, suppressor cells previously cultured in the presence of TGFb together with IL-27 inhibited the proliferation of CD4+CD25À cells considerably less (Fig. 3C) . As can be seen, the differences in the potency of inhibition were significant at responder to suppressor ratios 1:1, 1:4 and 1:8. Thus, IL-27-mediated down-regulation of Foxp3 was reflected in suppression of the phenotype and regulatory function of arising T h .
IL-27-mediated inhibition of the Treg phenotype is associated with maintained TNFa production
In order to characterize in more detail the T h arising after differentiation in the presence of TGFb and IL-27, we assessed the cytokine production. First, we examined the production of IL-4 and IL-17 by intracellular cytokine staining after restimulation of CD4+ T cells cultured under neutral conditions or in the presence of TGFb and IL-27 alone or in combination. In agreement with the known T h 2-and T h 17-inhibitory activity of IL-27 (9, 14, 15) , no IL-4-and IL-17-positive cells were detectable in the presence of IL-27 and TGFb (data not shown).
Next, we measured TNFa production ( Fig. 4A and B) . Confirming previous reports (18) , differentiation in the presence of IL-27 alone caused high TNFa production, whereas incubation with TGFb alone gave rise to low secretion of this cytokine, a result in agreement with the published Foxp3-mediated suppression of TNFa expression (24) . Addition of IL-27 to TGFb cultures induced a dose-dependent increase in TNFa production as compared with T h treated with TGFb alone (Fig. 4B) . In turn, TGFb partially inhibited IL-27-induced TNFa production (Fig. 4A) . Concluding, the amounts of TNFa produced by T h after differentiation in the presence of TGFb and IL-27 remained at the T h 0 level.
Since IL-27 was originally described as a T h 1-inducing factor, we also measured IFNc production. Consistent with the previous reports (10-12), T h differentiated in the presence of IL-27 produced high amounts of IFNc, while culture under Treg conditions caused very low secretion of this cytokine, confirming the published TGFb-mediated suppression of IFNc (40) . Interestingly, only very low levels of this T h 1 cytokine were detectable in re-stimulated cells after culture with IL-27 plus TGFb (Fig. 4C) , a result confirmed even in the presence of very high amounts of IL-27 (data not shown). To closer analyse the suppressive effect of TGFb on IL-27-mediated IFNc production, we performed mRNA analyses for the T h 1 lineage-specifying transcription factor T-bet and for IFNc 24 h after primary stimulation. Already at this early time point, the stimulatory effect of IL-27 on T-bet and IFNc expression was efficiently inhibited by TGFb (Fig. 4D  and E) , thus explaining the very low production of the T h 1 cytokine after re-stimulation (Fig. 4C) . These data show that TGFb blocks T h 1-skewing effects of IL-27 during CD4+ T-cell differentiation.
Collectively, these results demonstrate that IL-27 inhibits TGFb-mediated Treg cell differentiation as examined by the phenotype and suppressor function. The arising cells maintain IL-2 and TNFa production, but are suppressed in their capacity to secrete IFNc.
IL-27 induces the phosphorylation of STAT1 and STAT3 independently of the presence of TGFb
In the next step, we wanted to analyse the mechanism by which IL-27 inhibits the differentiation of Treg cells. As mentioned above, IL-27 induces the phosphorylation of STAT1 and STAT3 proteins both of which play an important role in T h function (8) (9) (10) . To confirm these data and to analyse whether the differentiation of CD4+ T cells in the presence of TGFb alters their phosphorylation profile, we performed immunoblot analyses. CD4+ T cells were stimulated for 24 h in the presence or absence of TGFb, rested for 2 h, IL-27 was added for 20, 60 or 120 min and subsequently the phosphorylation of STAT1 and STAT3 was determined in cell lysates. As shown in Fig. 5(A and B) , both STAT proteins were phosphorylated approximately at the same level independently of the presence or absence of TGFb during priming. Thus, IL-27 provokes efficient phosphorylation of STAT1 and STAT3 also after differentiation of CD4+ T cells under Treg conditions, suggesting that both proteins could be involved in IL-27-mediated suppression of Treg cell development.
STAT1 is not essential for IL-27-mediated Treg suppression
To determine whether STAT1 is involved in the IL-27-mediated inhibition of Treg differentiation, we comparatively Fig. 7 . IL-27 inhibits Treg cell differentiation via STAT3. CD4+ T cells were nucleofected with or without the indicated siRNA (scrambled, control; siRNA-1 and -2 against STAT3) and primed in the presence of the indicated cytokines as described for Fig. 1. (A) 48 h after the onset of the cultures, whole-cell lysates were prepared from cells differentiated in the presence of rhTGFb1 plus rmIL-27 followed by immunoblotting using antibodies against total STAT3, STAT1 and b-actin. (B and C) 72 h after the start of the culture, the cells were stained with anti-Foxp3-PE or IFNc-PE mAb and analysed by flow cytometry. Brefeldin A was added during the final 4 h of culture. Percentages of CD4+ T cells positive for intracellular Foxp3 or IFNc are shown after culture with rhTGFb1 alone or in combination with rmIL-27 or rmIL-6. Data are representative of at least three separate experiments. stimulated STAT1À/À and WT naive T h in the presence or absence of IL-27 plus TGFb alone or in combination, and then, after re-stimulation, intracellular Foxp3 and IL-2 were stained (Fig. 6 ). After culturing in the presence of TGFb, STAT1À/À cells expressed Foxp3 at the same level as WT cells. The addition of IL-27 with or without TGFb blocked Foxp3 expression in both STAT1À/À and WT cells; however, the inhibitory effect of IL-27 was even stronger in STAT1À/À cells than in WT cells (Fig. 6) . Thus, STAT1 was not responsible for the suppression of Foxp3 expression mediated by IL-27, but even partially neutralized this effect. As IL-6 is already known to inhibit Foxp3 via STAT3 (30, 31) , we used this cytokine as a control of our experimental system. Consistent with the published reports, IL-6 blocked the TGFbinduced Foxp3 expression at the same level in WT and STAT1À/À CD4+ T cells.
As mentioned above, IL-27 opposes IL-2 production via STAT1 (17) . In agreement with this published data, addition of IL-27 to both T h 0 and TGFb cultures created a higher percentage of IL-2 positivity in STAT1À/À cells compared with WT cells (Fig. 6) . Additionally, the presence of TGFb plus IL-27 led to the induction of IL-17-positive cells (4%) in cultures of STAT1À/À, but not WT cells (data not shown), again confirming previous reports (14) . Together, these results demonstrate that the transcripton factor STAT1 is not required for the suppressive effects of IL-27 on Foxp3 expression.
IL-27 inhibits the generation of Treg cells via STAT3
Common features of IL-6 and IL-27 are activation of the STAT3 transcription factor and simultaneous inhibiton of Foxp3 expression. Because IL-6 has been shown to downregulate Foxp3 via STAT3 (30, 31) and, as shown in Fig.  5(B) , IL-27 provokes efficient STAT3 phosphorylation even in the presence of TGFb, we hypothesized that STAT3 is involved in IL-27-mediated Foxp3 suppression. Therefore, we transiently reduced the expression of STAT3 protein in CD4+ T cells using siRNA against STAT3. As shown in Fig. 7(A) , both siRNA-1 and -2 specifically inhibited STAT3 expression after 48 h of CD4+ T-cell differentiation, while they had no influence on the level of STAT1 protein. Functionally, the knock down of STAT3 protein by both siRNA-1 and -2 significantly neutralized the inhibitory effect of IL-27 on TGFb-mediated up-regulation of Foxp3, as compared with cells nucleofected in the absence of siRNA or with scrambled control siRNA (Fig. 7B) . Confirming previous data, STAT3 down-regulation also attenuated the effect of IL-6 on TGFb-induced Foxp3 expression. The relative efficacy of STAT3 knock down was stronger in IL-6-treated cells than in cells cultured in the presence of TGFb and IL-27 (factors 4 versus 2, respectively). This observation suggests that other signal transduction pathways may be involved in IL-27-operated Foxp3 inhibition as well.
Apart from the effects on Foxp3 expression, silencing of STAT3 expression also caused a significant increase in the percentage of IFNc-positive T h cultured in the presence of TGFb and IL-27 (Fig. 7C) , indicating that STAT1 signal transduction was not only functionally intact but even more engaged by IL-27 under these conditions. A similar effect has been described for the cytokines IL-6 and IL-21, which in the absence of STAT3 induce high percentages of IFNcpositive cells (30, 32) .
In conclusion, STAT3 is the transcription factor that appears to be at least partially responsible for mediating IL-27-dependent negative regulation of Foxp3.
Discussion
In this study, we analyse in detail the very recently published observation that IL-27 negatively regulates the fate determination of Treg cells. The addition of IL-27 suppressed the TGFb-mediated Foxp3 expression and concomitantly reversed the TGFb-mediated inhibition of IL-2 production in arising cells. Thus, consistently with the reciprocal regulation of the Treg phenotype and IL-2 production (23, 24) , the suppression of Foxp3 expression by IL-27 correlated inversely with the appearance of IL-2. Previously, IL-27 was regarded solely as a negative regulator of IL-2 production (16, 17) and also in our experimental system, the addition of IL-27 to cells cultured under T h 0 conditions reduced their IL-2 production to some extent (Figs. 1C and 2C ). The IL-2 levels produced after incubation of T h in the presence of TGFb and IL-27 reflect the opposing capacities of IL-27; during priming, IL-2 production was reduced to a level smaller than in T h 0 cells, but significantly higher than in T h cells incubated with TGFb alone. In contrast, after re-stimulation, the arising T h produced IL-2 at the T h 0 level (Fig. 1B and C) . Thus, depending on the cytokine milieu, IL-27 shows opposite effects on IL-2 expression by T h . As Foxp3 downregulates IL-2 (24), the molecular mechanism by which IL-27 maintains IL-2 production in the presence of TGFb may include its capacity to suppress the expression of Foxp3.
IL-27 opposed the acquirement of the Treg phenotype not only with respect to Foxp3 expression and blockade of IL-2 production, i.e. anergy, but also as characterized by the Treg-associated markers CD25 and CTLA-4. Finally, the Treg suppressor function was also significantly affected by IL-27: after differentiation in the presence of TGFb plus IL-27, the cells had a weaker inhibitory activity on the proliferation of responder cells than after culture with TGFb alone (Fig. 3C) . Thus, IL-27 inhibited both TGFb-induced Treg phenotype and suppressor function.
The T h cells arising after polarization in the presence of TGFb and IL-27 produced increased amounts of TNFa as compared with T h cells differentiated in the presence of TGFb alone, but lower than cells cultured with IL-27 alone. Thus, these TNFa levels corresponded to that secreted by cells with a T h 0 phenotype. In the same culture conditions, the arising T h cells produced only low amounts of IFNc which contrasts with the known T h 1-skewing activity of IL-27. The suppressive effect of TGFb on IL-27-induced T h 1-master regulator T-bet and IFNc mRNA expression was already detectable after 24 h of differentiation ( Fig. 4D and E) . Furthermore, the cells generated after incubation in the presence of IL-27 and TGFb did not produce IL-4 or IL-17. In conclusion, the cells arising after commitment in the presence of IL-27 and TGFb acquire T h 0-like phenotype; they maintain IL-2 and TNFa production but secrete very low amounts of IFNc.
Mechanistically, the negative effect of IL-27 on Treg cell generation appears to be mediated at least partially via STAT3. After transient silencing of STAT3 protein expression in T h using siRNA, the capacity of IL-27 to block TGFbinduced Foxp3 expression was significantly reduced as compared with CD4+ T cells treated with scrambled control siRNA (Fig. 7B) . As mentioned above, IL-6 also suppresses Foxp3 expression and this effect was likewise described to be dependent on STAT3 (30, 31) . Therefore, our data are consistent with the idea that signals operated via the transcription factor STAT3 suppress Treg cell differentiation.
In contrast, STAT1 seems to antagonize the STAT3-mediated effects of IL-27 because we found that in STAT1À/À cells, IL-27 inhibited TGFb-mediated Foxp3 expression more efficiently and concomitantly induced stronger IL-2 production than in WT cells. This conclusion is supported by considering the previously published capacity of STAT3 to promote proliferation of T h in response to IL-6 (41) and to generate T h 17 via IL-6 in conjunction with TGFb (30) (31) (32) . All these effects of STAT3 are also visible after the addition of IL-27 to STAT1À/À cells. Therefore, IL-27 uses the phosphorylation of STAT1 and STAT3 with clearly distinct consequences; while STAT1 operates during induction of T h 1 differentiation, inhibition of IL-2 production and blockade of T h 17 development, STAT3 is involved in the suppression of Treg development as defined by Foxp3, CTLA-4 and CD25 expression, regulatory function, blockade of anergy and maintenance of TNFa production.
As Treg cells play an important role in the control of the immune system and the absence of Treg cells is associated with autoimmune disorders (19, 20) , our data could have significance for the in vivo situation. An example may be an inflammatory reaction in a tissue like the intestine, in which suppressive function of Treg cells is especially important for immune homeostasis. Under these conditions, induction of IL-27 and concomitant inhibition of Treg function with the appearance of TNFa-and IL-2-producing cells could be associated with autoimmunity. Supporting this idea, IL-27 expression is elevated in the colonic mucosa during Crohn's disease and the suppression of the disease is associated with normalization of the IL27p28 levels (42) . Furthermore, in a mouse colitis model, IL-27 signalling is associated with exacerbation of acute colonic inflammation (43) . Therefore, it will be interesting to more closely investigate the interplay of TGFb and IL-27 in vivo, for example during the induction of colitis.
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